BRAF and cancer: Second, the survival of patients with BRAFAMP and IDH1/2MT was comparable to that of patients with BRAF mutations and greater than that of patients with BRAFAMP and IDH1/2WT, probably because the IDH1/2 mutation and 2-HG can induce oxidative stress, autophagy, and apoptosis in cancer cells.